Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis

Annals of Neurology

Volumn 43, Issue 4, 1998, Pages 499-506

  Filippi, M ^a,l   Horsfield, M A ^b   Ader H J ^c   Barkhof, F ^c   Bruzzi, P ^a,d   Evans, A ^e   Frank, J A ^f   Grossman, R I ^g   McFarland, H F ^f   Molyneux, P ^h   Paty, D W ⁱ   Simon, J ^j   Tofts, P S ^h   Wolinsky, J S ^k   Miller, D H ^h  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF GENOA   (Italy)

^e MCGILL UNIVERSITY   (Canada)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j UNIVERSITY OF COLORADO   (United States)

^k UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^l SAN RAFFAELE HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; DATA ANALYSIS; HUMAN; MEASUREMENT; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY;

EID: 15144347576     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430414     Document Type: Article

References (64)

1. Paty DW, Li DKB, the UBC MS/MRI Study Group, the IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:662-667
2. The IFNB Multiple Sclerosis Study Group, the University of British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-1285
3. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452
4. Paty DW, Li DBK, Oger JJF, et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neural 1994;36:S95-S96
5. Stone LA, Albert PS, Smith ME, et al. Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis. Neurology 1995;45:1808-1814
6. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16
7. Filippi M, van Waesberghe JH, Horsfield MA, et al. Interscanner variation in brain MRI lesion load measurements in multiple sclerosis: implications for clinical trials. Neurology 1997;49:371-377
8. Gawne-Cain ML, Webb S, Tofts P, Miller DH. Lesion volume measurement in multiple sclerosis: how important is accurate repositioning? JMRI 1996;6:705-713
9. Simon JH, Scherzinger A, Raff U, Li X. Lesion volume quantification in multiple sclerosis: computerized method and potential errors in serial studies. Am J Neuroradiol (AJNR) 1997; 18:580-582
10. Udupa JK, Wei L, Samarasekera S, et al. Detection and quantification of MS lesions using fuzzy topographical principles. Image Processing 1996;2710:81-91
11. Filippi M, Marcianò N, Capra R, et al. The effect of imprecise repositioning on lesion volume measurements in patients with multiple sclerosis. Neurology 1997;49:274-276
12. Rovaris M, Gawne-Cain ML, Sormani MP, et al. The effect of repositioning errors on brain MRI lesion load measurements in multiple sclerosis [abstract]. Proc Int Soc Magn Reson Med 1997;1:650
13. Miller DH, Barkhof F, Berry I, et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 1991; 54:683-688
14. Evans AC, Frank JA, Antel J, Miller DH. The role of MRI in clinical trials of multiple sclerosis: comparison of image processing techniques. Ann Neurol 1997;41:125-132
15. Freeborough PA, Woods RP, Fox NC. Accurate registration of serial 3MR brain images and its application to visualizing change in neurodegenerative disorders. J Comput Assoc Tomogr 1996;20:1012-1022
16. Filippi M, Rocca MA, Horsfield MA, et al. Increased spatial resolution using a 3D T1-weighted gradient-echo sequence results in greater hypointense lesion volumes in multiple sclerosis. AJNR 1998 (In press)
17. Filippi M, Yousry T, Horsfield MA, et al. A high-resolution three-dimensional gradient echo sequence improves the detection of disease activity in multiple sclerosis. Ann Neurol 1996; 40:901-907
18. Filippi M, Horsfield MA, Campi A, et al. Resolution-dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis. Ann Neurol 1995;38:749-754
19. Hennig J, Nauerth A, Friedburg H. RARE imaging: a fast imaging method for clinical MR. Magn Reson Med 1986;3:823-833
20. Melki PS, Mulkern RV, Panych LP, Jolesz FA. Comparison of the FAISE method with conventional dual spin-echo sequences. JMRI 1991;1:319-326
21. Constable RT, Gore JC. The loss of small objects in variable TE imaging: implications for FSE, RARE and EPI. Magn Reson Imaging 1992;28:9-24
22. Thorpe JW, Halpin SF, MacManus DG, et al. A comparison between fast and conventional spin-echo in the detection of multiple sclerosis lesions. Neuroradiology 1994;36:388-392
23. Yousry TA, Filippi M, Becker C, et al. Comparison of SE, FSE, fast-FLAIR and TGSE sequences in detecting multiple sclerosis lesions. AJNR 1997;18:959-963
24. Rovaris M, Gawne-Cain ML, Wang L, Miller DH. A comparison of conventional and fast spin-echo sequences for the measurement of lesion load in multiple sclerosis using a semiautomated contouring technique. Neuroradiology 1997;39:161-165
25. Filippi M, Yousry T, Baratti C, et al. Quantitative assessment of MRI lesion load in multiple sclerosis: a comparison of conventional spin-echo with fast-fluid-attenuated inversion recovery. Brain 1996;119:1349-1355
26. Bastianello S, Bozzao A, Paolillo A, et al. Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions. AJNR 1997;18:699-704
27. Gawne-Cain ML, O'Riordan JI, Thompson AJ, et al. Multiple sclerosis lesion detection in the brain: a comparison of fast fluid attenuated inversion recovery and conventional T2 weighted dual spin echo. Neurology 1997;49:364-370
28. Filippi M, Yousry TA, Alkadhi H, et al. Spinal cord MRI in multiple sclerosis with multicoil arrays: a comparison between fast spin echo and fast FLAIR. J Neurol Neurosurg Psychiatry 1996;61:632-635
29. Stevenson VL, Gawne-Cain ML, Barker GJ, et al. Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast FLAIR and fast spin echo. J Neurol 1997; 244:119-124
30. Keiper MD, Grossman RI, Brunson JC, Schnall MD. The low sensitivity of fluid attenuated inversion recovery (FLAIR) imaging in the detection of multiple sclerosis of the spinal cord. AJNR 1997;18:1035-1039
31. Simon JH, Holtas SL, Schiffer RB, et al. Corpus callosum and subcallosal periventricular lesions in multiple sclerosis. Radiology 1986;160:363-367
32. Truyen L, Gheuens J, van de Vyver FL, et al. Improved correlation of magnetic resonance imaging (MRI) with clinical status in multiple sclerosis (MS) by use of an extensive standardized imaging protocol. J Neurol Sci 1990;96:173-182
33. Rovaris M, Sormani MP, Rocca MA, et al. The influence of slice orientation on brain MRI lesion load measurement in multiple sclerosis. Multiple Sclerosis 1998 (In press)
34. Filippi M, Horsfield MA, Bressi S, et al. Intra- and interobserver agreement of brain MRI lesion volume measurements in multiple sclerosis: a comparison of techniques. Brain 1995; 118:1583-1592
35. Grimaud J, Lai M, Thorpe J, et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 1996;14:495-505
36. 1-weighted) spin-echo images. Neurology 1995;45:1684-1690
37. Filippi M, Gawne-Cain ML, Gasperini C, et al. Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis. Neurology 1998;50:238-244
38. Bedell BJ, Narayana PA, Wolinsky JS. A dual approach for minimizing false lesion classifications on magnetic resonance images. Magn Reson Med 1997;37:94-102
39. Shavelson RJ, Webb NM. Generalizibity theory. London, Sage Publications, 1991
40. Tofts PS, Barker GJ, Filippi M, et al. An oblique cylinder contrast-adjusted (OCCA) phantom to measure the accuracy of MRI brain lesion volume estimation schemes in multiple sclerosis. Magn Reson Imaging 1997;15:183-192
41. Adams CWM. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull 1977;33:15-20
42. Allen IV, McKeown SR. A histological, histochemical and bochemical study of macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81-91
43. Dousset V, Grossman RI, Ramer NK, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992; 182:483-491
44. Barbosa S, Blumhardt LD, Roberts N, et al. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white mattet and the "invisible" lesion load. Magn Reson Imaging 1994;12:33-42
45. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-482
46. Loevner LA, Grossman RI, Cohen JA, et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;96:511-515
47. Narayanan S, Fu L, Pioro E, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997;41:385-391
48. van Buchem MA, McGowan JC, Kolson DL, et al. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632-636
49. Filippi M, Barker GJ, Horsfield MA, et al. Benign and secondary progressive multiple sclerosis: A preliminary quantitative MRI study. J Neurol 1994;241:246-251
50. Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with disability in multiple sclerosis. Ann Neurol 1994;36:62-67
51. De Stefano N, Matthews PM, Antel JP, et al. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995;38:901-909
52. Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axonal loss. Brain 1995;118:1583-1592
53. Matthews PM, Pioro E, Narayanan S, et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 1996;119:715-722
54. Losseff NA, Webb SL, O'Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996;119:701-708
55. Losseff NA, Wang L, Lai HM, et al. Progressive cerebral atrophy in multiple sclerosis: a serial MRI study. Brain 1996; 119: 2009-2019
56. Truyen L, van Waesberghe JHTM, van Walderveen MAA, et al. Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-1476
57. Filippi M, Campi A, Colombo B, et al. A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 1996;243:502-505
58. Filippi M, Colombo B, Rovaris M, et al. A longitudinal magnetic resonance imaging study of the cervical cord in multiple sclerosis. J Neuroimaging 1997;7:78-80
59. Rovaris M, Filippi M, Calori G, et al. Intra-observer reproducibility in measuring new MRI putative markers of demyelination and axonal loss in multiple sclerosis: comparison with conventional T2-weighted scans. J Neurol 1997;244:266-270
60. Stone LA, Smith ME, Albert PS, et al. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology 1995;45:1122-1126
61. Losseff NA, Kingsley DPE, McDonald WI, et al. Clinical and magnetic resonance imaging predictors in primary and secondary progressive multiple sclerosis. Multiple Sclerosis 1996;1: 218-222
62. Koudriavtseva T, Thompson AJ, Fiorelli M, et al. Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;62:285-286
63. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 1993;33:480-489
64. Barkhof F, Filippi M, van Waesberghe JH, et al. Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis. Neurology 1997;49:1682-1688